Skin cancer makes up 26% of claims for women under 29: Vitality

Breast cancer represented half of claims across all ages

Jaskeet Briah
clock • 1 min read

Skin cancer has been found as the most common type of cancer affecting women under the age of 29, making up one quarter (26%) of claims made to Vitality last year, the provider has revealed.

According to Vitality's claims data for 2023, another comment type of cancer affecting women under 29 was lymphoma (18%), while breast cancer made up 49% of claims across all ages. Breast cancer was also the most common cancer type for women aged over 30, followed by skin cancer (21%) and bowel cancer (6%). For male claimants, the most common cancers were prostate (28%) - which was particularly prevalent for men over 60, making up 75% of cancer claims for these individuals - and skin cancer (28%). Meanwhile, for men aged under 30, the most common cancers were haematological (25%), ...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on Individual Protection

Octopus Legacy launches life cover with Shepherds Friendly

Octopus Legacy launches life cover with Shepherds Friendly

Designed to reduce anxiety

Jaskeet Briah
clock 10 December 2025 • 2 min read
Aviva updates online trust process

Aviva updates online trust process

Digitised trust for individual protection

Cameron Roberts
clock 28 November 2025 • 1 min read
Fairer Finance adds former FCA chair to consumer board

Fairer Finance adds former FCA chair to consumer board

Charles Randell CBE joins

Jaskeet Briah
clock 28 November 2025 • 1 min read